Category: Clinical Trial Update Region: North America · United States Company: Eisai Inc

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
Merck

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!